COSMO Pharmaceuticals SA Share Price Swiss Exchange
Equities
LU1202320294
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Sales 2024 * | 264M 284M 256M 22.34B | Sales 2025 * | 242M 260M 235M 20.51B | Capitalization | 1.17B 1.26B 1.14B 99.56B |
---|---|---|---|---|---|
Net income 2024 * | 124M 133M 121M 10.51B | Net income 2025 * | 76M 81.78M 73.9M 6.44B | EV / Sales 2024 * | 4 x |
Net cash position 2024 * | 120M 129M 116M 10.13B | Net cash position 2025 * | 210M 226M 205M 17.84B | EV / Sales 2025 * | 3.99 x |
P/E ratio 2024 * |
9.55
x | P/E ratio 2025 * |
12.9
x | Employees | - |
Yield 2024 * |
2.87% | Yield 2025 * |
1.58% | Free-Float | 44.36% |
Latest transcript on COSMO Pharmaceuticals SA
Managers | Title | Age | Since |
---|---|---|---|
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 31/05/16 |
Chairman | 61 | 31/12/05 | |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 69 | 31/12/96 | |
Director/Board Member | 69 | 31/03/12 | |
Chairman | 61 | 31/12/05 |
1st Jan change | Capi. | |
---|---|---|
+55.55% | 816B | |
+40.88% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.51% | 238B | |
+1.60% | 222B | |
+13.53% | 218B | |
+7.87% | 167B |